RT Journal Article
SR Electronic
T1 The rapid reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-19 restrictions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.27.21257940
DO 10.1101/2021.05.27.21257940
A1 Hodjat, Parsa
A1 Christensen, Paul A.
A1 Subedi, Sishir
A1 Bernard, David W.
A1 Olsen, Randall J.
A1 Long, S. Wesley
YR 2021
UL http://medrxiv.org/content/early/2021/05/30/2021.05.27.21257940.abstract
AB Implementation of measures to limit the spread of the SARS-CoV-2 virus at the start of the COVID-19 pandemic resulted in a rapid decrease in all other respiratory pathogens. As COVID-19 containment measures were relaxed, the first non-COVID respiratory viruses to return to prepandemic levels were members of the rhinovirus/enterovirus, followed by the rapid return of seasonal coronaviruses, parainfluenza, and respiratory syncytial virus after the complete removal of COVID-19 precautions at the state level, including an end to mask mandates. Inasmuch as COVID-19 has dominated the landscape of respiratory infections since early 2020, it is important for clinicians to recognize the return of non-COVID respiratory pathogens may be rapid and significant when COVID-19 containment measures are removed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding supported this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The work was approved by the Houston Methodist Research Institute Institutional Review Board (IRB1010-0199).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for influenza, RSV, and rhinovirus/enterovirus is available on flu.houstonmethodist.org. Data for non-COVID coronaviruses is available from authors upon request. https://flu.houstonmethodist.org